Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP Registry
SGLT2抑制剂在真实世界人群中的成本效益:基于MICADO模型和全科医生注册中心常规数据的分析
期刊:Pharmacoeconomics
影响因子:4.6
doi:10.1007/s40273-023-01286-3
Li, Xinyu; Hoogenveen, Rudolf; El Alili, Mohamed; Knies, Saskia; Wang, Junfeng; Beulens, Joline W J; Elders, Petra J M; Nijpels, Giel; van Giessen, Anoukh; Feenstra, Talitha L